A 360 view of the inflammasome: Mechanisms of activation, cell death, and diseases

KC Barnett, S Li, K Liang, JPY Ting - Cell, 2023 - cell.com
Inflammasomes are critical sentinels of the innate immune system that respond to threats to
the host through recognition of distinct molecules, known as pathogen-or damage …

[HTML][HTML] Cytokine release syndrome and associated neurotoxicity in cancer immunotherapy

EC Morris, SS Neelapu, T Giavridis… - Nature Reviews …, 2022 - nature.com
A paradigm shift has recently occurred in the field of cancer therapeutics. Traditional
anticancer agents, such as chemotherapy, radiotherapy and small-molecule drugs targeting …

The NLR gene family: from discovery to present day

WC Chou, S Jha, MW Linhoff, JPY Ting - Nature Reviews Immunology, 2023 - nature.com
The mammalian NLR gene family was first reported over 20 years ago, although several
genes that were later grouped into the family were already known at that time. Although it is …

Programming inflammatory cell death for therapy

S Christgen, RE Tweedell, TD Kanneganti - Pharmacology & therapeutics, 2022 - Elsevier
Programmed cell death (PCD) is an essential part of organismal development and plays
fundamental roles in host defense against pathogens and the maintenance of homeostasis …

Emerging activators and regulators of inflammasomes and pyroptosis

Y Xue, DE Tuipulotu, WH Tan, C Kay, SM Man - Trends in immunology, 2019 - cell.com
The inflammasome is a cytosolic immune signaling complex that induces inflammation and
pyroptosis. Inflammasome complexes respond to a variety of pathogens, as well as danger …

[HTML][HTML] Caspases in cell death, inflammation, and disease

N Van Opdenbosch, M Lamkanfi - Immunity, 2019 - cell.com
Caspases are an evolutionary conserved family of cysteine proteases that are centrally
involved in cell death and inflammation responses. A wealth of foundational insight into the …

[HTML][HTML] Disease severity-specific neutrophil signatures in blood transcriptomes stratify COVID-19 patients

AC Aschenbrenner, M Mouktaroudi, B Krämer… - Genome medicine, 2021 - Springer
Abstract Background The SARS-CoV-2 pandemic is currently leading to increasing numbers
of COVID-19 patients all over the world. Clinical presentations range from asymptomatic …

Pediatric hemophagocytic lymphohistiocytosis

SW Canna, RA Marsh - Blood, The Journal of the American …, 2020 - ashpublications.org
Hemophagocytic lymphohistiocytosis (HLH) is a syndrome describing patients with severe
systemic hyperinflammation. Characteristic features include unremitting fever, cytopenias …

[HTML][HTML] Immune effector cell-associated hemophagocytic lymphohistiocytosis-like syndrome

MR Hines, TE Knight, KO McNerney, MB Leick… - … and Cellular Therapy, 2023 - Elsevier
Background T cell mediated hyperinflammatory responses such as cytokine release
syndrome (CRS) and immune effector cell associated neurotoxicity syndrome (ICANS) are …

The IL-1 family of cytokines and receptors in rheumatic diseases

CA Dinarello - Nature Reviews Rheumatology, 2019 - nature.com
More than any other cytokine family, the 11 members of the IL-1 family are associated with
innate immune responses, which occur in acute inflammation and chronic inflammatory …